Document is current

Article History

First Online: 2 March 2019

Compliance with Ethical Standards

:

: This article was funded by Pfizer Inc, New York, NY, USA. The article processing charge for open access was funded by Pfizer Inc, New York, NY, USA.

: Geert R.A.M. D’Haens has received consulting fees from AbbVie, Ablynx, Amakem, AM Pharma, Avaxia, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion, Cosmo, Covidien/Medtronics, Dr. Falk Pharma, Engene, Ferring, Galapagos, Gilead, GlaxoSmithKline, Hospira, Immunic, Johnson and Johnson, Lycera, Medimetrics, Millennium/Takeda, Mitsubishi Pharma, MSD, Mundipharma, Novo Nordisk, Pfizer Inc, Prometheus Laboratories/Nestle, Receptos, Robarts Clinical Trials, Salix, Sandoz, Setpoint, Shire, Teva, Tigenix, Tillotts, Topivert, Versant, and Vifor; research grants from AbbVie, Falk, Ferring, MSD, Mundipharma, and Takeda; and lecture and/or speaker bureau fees from AbbVie, Ferring, Johnson and Johnson, Millennium/Takeda, MSD, Mundipharma, Norgine, Pfizer Inc, Shire, Tillotts, and Vifor. James O. Lindsay has received consulting fees from AbbVie, Celgene, Ferring, Janssen, Merck, Pfizer Inc, Robarts Clinical Trials, Shire, and Takeda; research grants from Pfizer Inc/Hospira, MSD, Shire, and Takeda; lecture and/or speaker bureau fees from AbbVie, Allergan, Ferring, Janssen, MSD, Shire, and Takeda; and advisory board fees from AbbVie, Atlantic Healthcare, Ferring, Hospira, Janssen, MSD, NAP, Pfizer Inc, Shire, Takeda, and Vifor. Remo Panaccione has received consulting fees from AbbVie, Amgen, Aptalis, AstraZeneca, Baxter, Biogen, Bristol-Myers Squibb, Celgene, Centocor, Cubist, Eisai, Elan, Ferring, Gilead, GlaxoSmithKline, Janssen, Merck, Pfizer Inc, Robarts Clinical Trials, Salix, Samsung Bioepis, Shire, Takeda, and UCB; research grants from AbbVie, Ferring, Janssen, and Takeda; lecture and/or speaker bureau fees from AbbVie, Aptalis, AstraZeneca, Ferring, Janssen, Merck, Prometheus, Shire, and Takeda; and advisory board fees from Abbott, AbbVie, Amgen, Aptalis, AstraZeneca, Baxter, Bristol-Myers Squibb, Celgene, Centocor, Cubist, Eisai, Elan, Ferring, Genentech, GlaxoSmithKline, Janssen, Merck, Pfizer Inc, Salix, Schering-Plough, Shire, Takeda, and UCB. Stefan Schreiber has received consulting fees from AbbVie, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Ferring, Galapagos, Janssen, MedImmune, MSD, Pfizer Inc/Hospira, Shire, Takeda, and UCB; and lecture and/or speaker bureau fees from AbbVie, Falk, Ferring, MSD, Takeda, and UCB.